LucasPye Bio Capacity Update October 2022: Large Molecule

In the October 2022 edition of the Outsourced Pharma Capacity Update, LucasPye Bio tours its facilities, presenting its capabilities and capacity, and explains how they help promote novel biologics, including biosimilars and biobetters, by offering its bioprocessing services below market price to start-up life science companies, small biopharmaceutical companies, and non-profit organizations that financially support new biologics discovered by the aforementioned entities.